The GSTM1 and GSTT1 Null Genotypes Increase the Risk for Type 2 Diabetes Mellitus and the Subsequent Development of Diabetic Complications: A Meta-analysis

Author(s): Sayantan Nath, Sambuddha Das, Aditi Bhowmik, Sankar Kumar Ghosh, Yashmin Choudhury*.

Journal Name: Current Diabetes Reviews

Volume 15 , Issue 1 , 2019

Become EABM
Become Reviewer

Abstract:

Background: Studies pertaining to association of GSTM1 and GSTT1 null genotypes with risk of T2DM and its complications were often inconclusive, thus spurring the present study.

Methods: Meta-analysis of 25 studies for evaluating the role of GSTM1/GSTT1 null polymorphisms in determining the risk for T2DM and 17 studies for evaluating the role of GSTM1/GSTT1 null polymorphisms in development of T2DM related complications were conducted.

Results: Our study revealed an association between GSTM1 and GSTT1 null polymorphism with T2DM (GSTM1; OR=1.37;95% CI =1.10-1.70 and GSTT1; OR=1.29;95% CI =1.04-1.61) with an amplified risk of 2.02 fold for combined GSTM1-GSTT1 null genotypes. Furthermore, the GSTT1 null (OR=1.56;95%CI=1.38-1.77) and combined GSTM1-GSTT1 null genotypes (OR=1.91;95%CI=1.25- 2.94) increased the risk for development of T2DM related complications, but not the GSTM1 null genotype. Stratified analyses based on ethnicity revealed GSTM1 and GSTT1 null genotypes increase the risk for T2DM in both Caucasians and Asians, with Asians showing much higher risk of T2DM complications than Caucasians for the same.

Discussion: GSTM1, GSTT1 and combined GSTM1-GSTT1 null polymorphism may be associated with increased risk for T2DM; while GSTT1 and combined GSTM1-GSTT1 null polymorphism may increase the risk of subsequent development of T2DM complications with Asian population carrying an amplified risk for the polymorphism.

Conclusion: Thus GSTM1 and GSTT1 null genotypes increases the risk for Type 2 diabetes mellitus alone, in combination or with regards to ethnicity.

Keywords: Genetic polymorphism, glutathione S-transferases, meta-analysis, type 2 diabetes mellitus, GSTM1, GSTT1.

[1]
Bonnefond A, Froguel P, Vaxillaire M. The emerging genetics of type 2 diabetes. Trends Mol Med 2010; 16(9): 407-16.
[2]
Kota SK, Meher LK, Jammula S, Modi KD. Genetics of type 2 diabetes mellitus and other specific types of diabetes; its role in treatment modalities. Diabetes Metab Syndr 2012; 6(1): 54-8.
[3]
Antonioli L, Blandizzi C, Csoka B, Pacher P, Hasko G. Adenosine signalling in diabetes mellitus-pathophysiology and therapeutic considerations. Nat Rev Endocrinol 2015; 11(4): 228-41.
[4]
Phaniendra A, Jestadi DB, Periyasamy L. Free radicals: properties, sources, targets, and their implication in various diseases. Indian J Clin Biochem 2015; 30(1): 11-26.
[5]
Petrovic D, Peterlin B. GSTM1-null and GSTT1-null genotypes are associated with essential arterial hypertension in patients with type 2 diabetes. Clin Biochem 2014; 47(7-8): 574-7.
[6]
Hayes JD, Strange RC. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 2000; 61(3): 154-66.
[7]
Gonul N, Kadioglu E, Kocabas NA, Ozkaya M, Karakaya AE, Karahalil B. The role of GSTM1, GSTT1, GSTP1, and OGG1 polymorphisms in type 2 diabetes mellitus risk: a case-control study in a Turkish population. Gene 2012; 505(1): 121-7.
[8]
Pinheiro DS, Rocha FCR, Mundim CA, et al. Evaluation of glutathione S-transferase GSTM1 and GSTT1 deletion polymorphisms on type-2 diabetes mellitus risk. PLoS One 2013; 8(10): e76262.
[9]
Mastana SS, Kaur A, Hale R, Lindley MR. Influence of glutathione S-transferase polymorphisms (GSTT1, GSTM1, GSTP1) on type-2 diabetes mellitus (T2D) risk in an endogamous population from north India. Mol Biol Rep 2013; 40(12): 7103-10.
[10]
Yalin S, Hatungil R, Tamer L, et al. Ates NA, Dogruer N, Yildirim H, etal Glutathione S-transferase gene polymorphisms in Turkish patients with diabetes mellitus. Cell Biochem Funct 2007; 25(5): 509-13.
[11]
Raza S, Abbas S, Ahmad A, Ahmed F, Zaidi Z, Mahdi F. Association of Glutathione-S-Transferase (GSTM1 and GSTT1) and FTO gene polymorphisms with type 2 diabetes mellitus cases in northern india. Balkan J Med Genet 2014; 17(1): 47-54.
[12]
Rao DK, Shaik NA, Imran A, et al. Variations in the GST activity are associated with single and combinations of GST genotypes in both male and female diabetic patients. Mol Biol Rep 2014; 41(2): 841-8.
[13]
Amer MA, Ghattas MH, Abo-Elmatty DM, Abou-El-Ela SH. Influence of glutathione S-transferase polymorphisms on type-2 diabetes mellitus risk. Genet Mol Res 2011; 10(4): 3722-30.
[14]
Wang G, Zhang L, Li Q. Genetic polymorphisms of GSTT1, GSTM1, and NQO1 genes and diabetes mellitus risk in Chinese population. Biochem Biophys Res Commun 2006; 341(2): 310-3.
[15]
Ramprasath T, Senthil Murugan P, Prabakaran AD, Gomathi P, Rathinavel A, Selvam GS. Potential risk modifications of GSTT1, GSTM1 and GSTP1 (glutathione-S-transferases) variants and their association to CAD in patients with type-2 diabetes. Biochem Biophys Res Commun 2011; 407(1): 49-53.
[16]
Zaki MA, Moghazy TF, El-Deeb MMK, Mohamed AH, Mohamed NAA. Glutathione S-transferase M1, T1 and P1 gene polymorphisms and the risk of developing type 2 diabetes mellitus in Egyptian diabetic patients with and without diabetic vascular complications. Alexandria J Med 2015; 51(1): 73-82.
[17]
Vats P, Chandra H, Banerjee M. Glutathione S-transferase and Catalase gene polymorphisms with Type 2 diabetes mellitus. Dis Mol Med 2013; 1(3): 46-53.
[18]
Moasser E, Kazemi-Nezhad SR, Saadat M, Azarpira N. Study of the association between glutathione S-transferase (GSTM1, GSTT1, GSTP1) polymorphisms with type II diabetes mellitus in southern of Iran. Mol Biol Rep 2012; 39(12): 10187-92.
[19]
Hori M, Oniki K, Ueda K, Goto S, Mihara S, Marubayashi T, et al. Combined glutathione S-transferase T1 and M1 positive genotypes afford protection against type 2 diabetes in Japanese. Pharmacogenomics 2007; 8(10): 1307-14.
[20]
Nowier SR, Kashmiry NK, Rasool HA, Morad H, Ismail S. Association of Type 2 diabetes mellitus and glutathione S-transferase (GSTM1 and GSTT1) genetic polymorphism. Res J Med Medical Sci 2009; 4(2): 181-8.
[21]
Afrand M, Khalilzadeh S, Bashardoost N, Sheikhha MH. Evaluation of glutathione S-transferase T1 deletion polymorphism on type 2 diabetes mellitus risk in Zoroastrian females in Yazd, Iran. Indian J Endocrinol Metab 2015; 19(1): 124-8.
[22]
Al-Badran AI, Al-Mayah MK. Association between GSTT1 and GSTM1 genes polymorphisms Type II diabetes miletus patients in Basra Iraq. Int J Curr Microbiol Appl Sci 2014; 3(11): 288-99.
[23]
Rasheed MN, Hasan OM, Mahmood AS. Association of Glutathione S-Transferase (GSTM1, T1) Gene Polymorphisms with Type 2 Diabetes Mellitus (T2DM) in the Iraqi Patients. Iraqi J Biotechnol 2015; 14(1): 70-6.
[24]
Hayek T, Stephens JW, Hubbart CS, et al. A common variant in the glutathione S transferase gene is associated with elevated markers of inflammation and lipid peroxidation in subjects with diabetes mellitus. Atherosclerosis 2006; 184(2): 404-12.
[25]
Etemad A, Vasudevan R, Aziz AF, et al. Analysis of selected glutathione S-transferase gene polymorphisms in Malaysian type 2 diabetes mellitus patients with and without cardiovascular disease. Genet Mol Res 2016; 15(2)
[26]
Moasser E, Azarpira N, Shirazi B, Saadat M, Geramizadeh B. Genetic polymorphisms of glutathione-s-transferase M1 and T1 genes with risk of diabetic retinopathy in Iranian population. Iran J Basic Med Sci 2014; 17(5): 351-6.
[27]
Stoian A, Banescu C, Balasa RI, et al. Influence of GSTM1, GSTT1, and GSTP1 Polymorphisms on Type 2 Diabetes Mellitus and Diabetic Sensorimotor Peripheral Neuropathy Risk. Dis Markers 2015; 2015: 638693.
[28]
Datta SK, Kumar V, Pathak R, et al. Association of glutathione S-transferase M1 and T1 gene polymorphism with oxidative stress in diabetic and nondiabetic chronic kidney disease. Ren Fail 2010; 32(10): 1189-95.
[29]
Tsai JP, Yang SF, Wu SW, et al. Glutathione S-transferase gene polymorphisms are not major risks for susceptibility to posttransplantation diabetes mellitus in Taiwan renal transplant recipients. J Clin Lab Anal 2011; 25(6): 432-5.
[30]
Bid HK, Konwar R, Saxena M, Chaudhari P, Agrawal CG, Banerjee M. Association of glutathione S-transferase (GSTM1, T1 and P1) gene polymorphisms with type 2 diabetes mellitus in north Indian population. J Postgrad Med 2010; 56(3): 176-81.
[31]
Purkait P, Halder K, Roy A. GSTM1 null genotype associated with type 2 diabetic nephropathy patients among Indian population. World J Pharm Res 2014; 3: 4452-63.
[32]
Kariz S, Nikolajevic Starcevic J, Petrovic D. Association of manganese superoxide dismutase and glutathione S-transferases genotypes with myocardial infarction in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 2012; 98(1): 144-50.
[33]
Turkanoglu A, Can Demirdogen B, Demirkaya S, Bek S, Adali O. Association analysis of GSTT1, GSTM1 genotype polymorphisms and serum total GST activity with ischemic stroke risk. Neurol Sci 2010; 31(6): 727-34.
[34]
Wang R, Wang Y, Wang J, Yang K. Association of glutathione S-transferase T1 and M1 gene polymorphisms with ischemic stroke risk in the Chinese Han population. Neural Regen Res 2012; 7(18): 1420-7.
[35]
Dadbinpour A, Sheikhha MH, Darbouy M, Afkhami-Ardekani M. Investigating GSTT1 and GSTM1 null genotype as the risk factor of diabetes type 2 retinopathy. J Diabetes Metab Disord 2013; 12(1): 48.
[36]
Cilensek I, Mankoc S, Petrovic MG, Petrovic D. GSTT1 null genotype is a risk factor for diabetic retinopathy in Caucasians with type 2 diabetes, whereas GSTM1 null genotype might confer protection against retinopathy. Dis Markers 2012; 32(2): 93-9.
[37]
Makuc J, Petrovic D. Diabetic nephropathy in type 2 diabetes: MPO T-764C genotype is associated with oxidative stress. Open Life Sci 2012; 7(6): 964-72.
[38]
Yang Y, Kao MT, Chang CC, et al. Glutathione S-transferase T1 deletion is a risk factor for developing end-stage renal disease in diabetic patients. Int J Mol Med 2004; 14(5): 855-9.
[39]
Fujita H, Narita T, Meguro H, Shimotomai T, Kitazato H, Kagaya E, et al. No association of glutathione S-transferase M1 gene polymorphism with diabetic nephropathy in Japanese type 2 diabetic patients. Ren Fail 2000; 22(4): 479-86.
[40]
Tang ST, Wang CJ, Tang HQ, Zhang Q, Wang Y. Evaluation of glutathione S-transferase genetic variants affecting type 2 diabetes susceptibility: a meta-analysis. Gene 2013; 530(2): 301-8.
[41]
Zhang J, Liu H, Yan H, Huang G, Wang B. Null genotypes of GSTM1 and GSTT1 contribute to increased risk of diabetes mellitus: a meta-analysis. Gene 2013; 518(2): 405-11.
[42]
Cochran WG. The comparison of percentages in matched samples. Biometrika 1950; 37(3-4): 256-66.
[43]
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327(7414): 557-60.
[44]
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7(3): 177-88.
[45]
Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22(4): 719-48.
[46]
Stuck AE, Rubenstein LZ, Wieland D. Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ 1998; 316(7129): 469-71.
[47]
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315(7109): 629-34.
[48]
Hanene C, Jihene L, Jamel A, Kamel H, Agnes H. Association of GST genes polymorphisms with asthma in Tunisian children. Mediators Inflamm 2007; 2007: 19564.
[49]
Josephy PD. Genetic variations in human glutathione transferase enzymes: significance for pharmacology and toxicology. Hum Genomics Proteomics 2010; 2010: 876940.
[50]
Saadat M. Null genotypes of glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) polymorphisms increased susceptibility to type 2 diabetes mellitus, a meta-analysis. Gene 2013; 532(1): 160-2.
[51]
Miller MC 3rd, Mohrenweiser HW, Bell DA. Genetic variability in susceptibility and response to toxicants. Toxicol Lett 2001; 120(1-3): 269-80.
[52]
Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995; 30(6): 445-600.
[53]
Orlewski J, Orlewska E. Effects of genetic polymorphisms of glutathione S-transferase genes (GSTM1, GSTT1, GSTP1) on the risk of diabetic nephropathy: a meta-analysis. Pol Arch Med Wewn 2015; 125(9): 649-58.
[54]
Sun L, Zhang Y, Xiong Y. GSTM1 and GSTT1 null genotype and diabetic retinopathy: a meta-analysis. Int J Clin Exp Med 2015; 8(2): 1677-83.
[55]
Ginsberg G, Smolenski S, Hattis D, Guyton KZ, Johns DO, Sonawane B. Genetic Polymorphism in Glutathione Transferases (GST): Population distribution of GSTM1, T1, and P1 conjugating activity. J Toxicol Environ Health B Crit Rev 2009; 12(5-6): 389-439.
[56]
Bailey LR, Roodi N, Verrier CS, Yee CJ, Dupont WD, Parl FF. Breast cancer and CYPIA1, GSTM1, and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and African Americans. Cancer Res 1998; 58(1): 65-70.
[57]
Strange RC, Fryer AA. The glutathione S-transferases: influence of polymorphism on cancer susceptibility. IARC Sci Publ 1999; (148): 231-49.
[58]
Huedo-Medina TB, Sanchez-Meca J, Marin-Martinez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods 2006; 11(2): 193-206.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 15
ISSUE: 1
Year: 2019
Page: [31 - 43]
Pages: 13
DOI: 10.2174/1573399814666171215120228
Price: $65

Article Metrics

PDF: 39
HTML: 10
PRC: 2